|
Market Closed -
Australian S.E.
09:20:43 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.670 AUD | +11.25% |
|
+15.09% | +61.33% |
| 09-11 | PYC Therapeutics Says First Patient Dosed in Open-Label Extension of Drug Candidate Study in Polycystic Kidney Disease | MT |
| 09-04 | PYC Therapeutics Limited - Special Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PYC THERAPEUTICS LIMITED | Other Biotechnology & Medical Research | +11.25% | +15.09% | +61.33% | +214.12% | +78.00% | 1.68B |  |  | |
- Stock Market
- Stocks
- PYC Stock
- Charts PYC Therapeutics Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
